Document ID: chunk:federal_register_of_legislation:F2025L00049:schedule:4:p6
Version: federal_register_of_legislation:F2025L00049
Segment Type: schedule
Provision Reference: sch 4 (pt 6/22)
Character Range: 197108–200835

tissue augmentation; or
 (b) for cosmetic use.
COLLAGENASE CLOSTRIDIUM HISTOLYTICUM.
COLURACETAM.
CONCIZUMAB.
CONVALLARIA KEISKI.
CONVALLARIA MAJALIS.
COPPER COMPOUNDS for human use except:
 (a) when separately specified in these Schedules; or
 (b) in preparations for human internal use containing 5 mg or less of copper per recommended daily dose; or
 (c) in other preparations containing 5% or less of copper compounds.
# CORIFOLLITROPIN ALFA.
CORONILLA spp.
CORTICOSTERONE.
CORTICOTROPHIN.
CORTISONE.
CO‑TRIMOXAZOLE.
COUMARIN for therapeutic use (excluding when present as an excipient).
CRISABOROLE.
CRIZOTINIB.
CROFELEMER.
CUPRIMYXIN.
CURARE.
CYCLANDELATE.
CYCLIZINE except when included in Schedule 3.
CYCLOBENZAPRINE.
# CYCLOFENIL.
CYCLOHEXIMIDE.
CYCLOPENTHIAZIDE.
CYCLOPENTOLATE.
CYCLOPHOSPHAMIDE.
CYCLOPROPANE for therapeutic use.
CYCLOSERINE.
CYCLOTHIAZIDE.
CYCRIMINE.
CYMARIN.
CYPROHEPTADINE except when included in Schedule 3.
CYPROTERONE.
CYTARABINE.
CYTISINE except when included in Schedule 3.
DABRAFENIB MESILATE.
DABIGATRAN.
DACARBAZINE.
DACLATASVIR.
DACLIZUMAB.
DACTINOMYCIN.
DALFOPRISTIN.
DALTEPARIN (includes dalteparin sodium).
DANAPAROID (includes danaparoid sodium).
# DANAZOL.
DANICOPAN.
DANTHRON for human use.
DANTROLENE.
DAPAGLIFLOZIN.
DAPOXETINE.
DAPSONE.
DAPTOMYCIN.
DARATUMUMAB.
# DARBEPOETIN.
DARIFENACIN.
DAROLUTAMIDE.
DARUNAVIR.
DATURA spp. except:
 (a) when included in Schedule 2; or
 (b) when separately specified in this Schedule.
DASABUVIR.
DASATINIB.
DATURA STRAMONIUM (stramonium) except:
 (a) when included in Schedule 2; or
 (b) for smoking or burning.
DATURA TATULA (stramonium) except:
 (a) when included in Schedule 2; or
 (b) for smoking or burning.
DAUNORUBICIN.
DEANOL for therapeutic use.
DEBRISOQUINE.
DECAMETHONIUM.
DECITABINE.
DEFERASIROX.
DEFERIPRONE.
DEFIBROTIDE.
DEFLAZACORT.
DEGARELIX.
# DEHYDROCHLOROMETHYLTESTOSTERONE.
DEHYDROCORTICOSTERONE.
DELAVIRDINE MESILATE.
DEMBREXINE except when included in Schedule 5.
DEMECARIUM.
DEMECLOCYCLINE.
DENGUE VACCINE.
DENOSUMAB.
DEOXYCHOLIC ACID.
DEOXYCORTONE.
DEOXYRIBONUCLEASE except:
 (a) when separately specified in this Schedule; or
 (b) for external use.
DERACOXIB.
DERMATOPHAGOIDES PTERONYSSINUS AND DERMATOPHAGOIDES FARINAE EXTRACT.
DESFERRIOXAMINE.
DESFLURANE.
DESIPRAMINE.
DESIRUDIN.
DESLANOSIDE.
DESLORATADINE except:
 (a) when included in Schedule 2; or
 (b) in divided preparations for oral use for the treatment of seasonal allergic rhinitis in adults and children 6 years of age and over, when:
  (i) in a primary pack containing 10 dosage units or less; and
  (ii) labelled with a recommended daily dose not exceeding 5 mg of desloratadine.
DESLORELIN.
DESMOPRESSIN (D.D.A.V.P.).
DESOGESTREL.
DESONIDE.
DESOXYMETHASONE.
DESVENLAFAXINE.
DETOMIDINE.
DEUCRAVACITINIB.
DEUTETRABENAZINE.
DEXAMETHASONE.
DEXCHLORPHENAMINE except when included in Schedule 2 or 3.
DEXFENFLURAMINE.
DEXMEDETOMIDINE.
DEXRAZOXANE.
DEXTROMETHORPHAN (excluding its stereoisomers) except when included in Schedule 2.
# DEXTROPROPOXYPHENE:
 (a) in divided preparations containing 135 mg of dextropropoxyphene or less per dosage unit; or
 (b) liquid preparations containing 2.5% or less of dextropropoxyphene.
DEXTRORPHAN (excluding its stereoisomers).
DIAMTHAZOLE.
DIAVERIDINE.
# DIAZEPAM.
DIAZOXIDE.
DIBENZEPIN.
DIBOTERMIN.
DIBROMOPROPAMIDINE for therapeutic use except when included in Schedule 2.
DICHLORALPHENAZONE.
DICHLOROPHEN for human therapeutic use.
DICHLORPHENAMIDE.
DICLOFENAC except:
 (a) when included in Schedule 2 or 3; or
 (b) in preparations for dermal use unless:

          (i) for the treatment of solar keratosis; or

          (ii) containing more than 4% of diclofenac.
DICLOXACILLIN.
DICYCLOMINE.
DIDANOSINE.
DIENESTROL.